IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
34 hedge funds and large institutions have $22.5M invested in Insight Molecular Diagnostics Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
34
Holders Change
–
Holders Change %
0%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
11
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$18.2M |
2 |
AG
2
Artal Group
Luxembourg
|
$893K |
3 |
3
BlackRock
New York
|
$485K |
4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$866K |
5 |
5
Goldman Sachs
New York
|
$219K |